Muscular strength and bone mineral density in haemodialysis patients
نویسندگان
چکیده
منابع مشابه
Leptin and bone mineral density in haemodialysis patients.
INTRODUCTION There are very few data about relations between leptin and bone mineral density (BMD) in regular haemodialysed patients. We aimed to examine the relationship of serum leptin levels with BMD values in dialysed patients. We also assessed whether leptin is a significant predictor of BMD in haemodialysed patients. MATERIALS AND METHODS Leptin levels were studied using commercially av...
متن کاملBone markers and bone mineral density in Duchenne muscular dystrophy.
All bone formation markers were significantly lower in the patient group compared with the control group; BALP (p=0.002), PINP (p<0.001) and OC (p<0.001). Significantly lower values for the bone resorption markers CTX (p<0.001) and TRACP5b (p=0.002) were also observed, however, not for ICTP (p=0.087). The CTX/TRACP5b quotient (a suggested index of the osteoclast activity in relation to the numb...
متن کاملBone Mineral Density and Bone Metabolism in Patients with Duchenne Muscular Dystrophy
Objective Poor bone health with related morbidity is a major problem with Duchene Muscular Dystrophy (DMD). Decreased mobility and long-term corticosteroid therapy are involved in poor bone health in DMD. We investigated bone mineral density and bone metabolism in 30 steroid treated DMD patients and also compared mentioned factors between ambulated and non-ambulated patients. Materials & Meth...
متن کاملMuscular strength measurements indicate bone mineral density loss in postmenopausal women
BACKGROUND The literature is inconsistent and inconclusive on the relationship between bone mineral density (BMD) and muscular strength in postmenopausal women. OBJECTIVE To evaluate the relationship between isokinetically and isometrically determined muscle strength and BMD in postmenopausal women of different age groups. METHODS Healthy postmenopausal women (n = 293; mean age, 54.22 ± 3.8...
متن کاملSclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
BACKGROUND Sclerostin is a soluble inhibitor of osteoblast function. Sclerostin is downregulated by the parathyroid hormone (PTH). Here, it was investigated whether sclerostin levels are influenced by intact (i) PTH and whether sclerostin is associated with bone turnover, microarchitecture and mass in dialysis patients. METHODS Seventy-six haemodialysis patients and 45 healthy controls were i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 1997
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/12.1.128